Philip Rosenthal, MD

Phone: 415-476-5892
UCSF Box: 0136
Email: [email protected]
UCSF Profile

Project Sponsor
Location(s) Topics Start End
A Phase 2 Multicenter, Single Dose, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination with Phototherapy in Neonates United States Newborn and Infant Health
A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children with Chronic HCV Infection Gilead Sciences, Inc. United States Pharmacology and Drug Treatment
A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients with Chronic Hepatitis B Infection Gilead Sciences, Inc. United States Infectious Disease
Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection Gilead Sciences, Inc. United States Infectious Disease, Pharmacology and Drug Treatment
GS-US-334-1113: A Phase 4, a Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Diret Acting Antiviral (DAA) in Gilead- Sponsored Chronic Hepatitis C Infection Trial Gilead Sciences, Inc. United States Drug and Diagnostics Development
Childhood Liver Disease Research and Education Network (ChiLDREN) - UCSF (CC) NIH National Institute of Diabetes and Digestive and Kidney Diseases United States Pediatrics
A 48-52 Month Blinded-Outcomes Follow up Study of Patients Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-205 Quintiles, Inc United States